https://medicaex.com/prnewswire/origin-agritech-announces-addition-to-two-ftse-russell-equity-indices/ 2022-09-12T13:00:15+00:00 https://medicaex.com/prnewswire/zeiss-integrated-workflow-solutions-are-creating-the-digital-transformation-in-healthcare/ 2022-09-12T00:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/09/ZEISS_Medical_Ecosystem_key_visual-KFSAvz.jpeg https://medicaex.com/prnewswire/kazia-to-present-final-data-from-paxalisib-phase-ii-study-in-glioblastoma-at-esmo/ 2022-09-12T00:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Kazia_Logo-b7QcVz.jpeg https://medicaex.com/prnewswire/novavax-nuvaxovid-covid-19-vaccine-approved-in-south-korea-for-use-in-adolescents-aged-12-through-17/ 2022-09-11T13:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/Novavax_High_Res_Logo-vDHhNF.jpeg https://medicaex.com/prnewswire/wetrade-group-inc-announces-us50-million-sales-of-monkeypox-virus-test-kits-to-parkway-medical-limited/ 2022-09-11T10:00:25+00:00 https://medicaex.com/prnewswire/jacobio-receives-cde-approval-for-kras-g12c-inhibitor-jab-218822s-phase-ii-pivotal-study-in-china/ 2022-09-10T13:00:49+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-2jMUfo.jpeg https://medicaex.com/prnewswire/dizal-announces-sunvozertinib-meets-primary-endpoint-in-its-first-pivotal-study-in-platinum-pretreated-nsclc-patients-with-egfr-exon20ins-mutations-at-2022-esmo/ 2022-09-09T22:00:49+00:00 https://medicaex.com/prnewswire/yishengbio-received-approvals-from-philippines-and-uae-for-phase-2-3-clinical-trials-of-pika-recombinant-covid-19-vaccine/ 2022-09-09T22:00:30+00:00 https://medicaex.com/prnewswire/panacell-biotech-to-conduct-toxicity-tests-for-nk-cells-exosomes-and-brown-adipose-derived-stem-cells-to-treat-patients-with-long-covid/ 2022-09-09T13:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/09/Seung_Ho_Choi__CEO_of_Panacell_Biotech_2-2rFRwz.jpeg https://medicaex.com/prnewswire/one-drug-for-one-bug-debiopharm-to-discuss-the-potential-of-pathogen-specific-antibiotics-at-the-2022-world-amr-congress/ 2022-09-09T12:00:27+00:00 https://medicaex.com/prnewswire/wetrade-group-entered-into-a-strategic-partnership-with-jiqing-acquiring-monkeypox-test-kits-exclusive-sales-channel/ 2022-09-09T12:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_1-T0uPSM.jpeg https://medicaex.com/prnewswire/uc-davis-new-research-shows-how-total-body-pet-imaging-can-assess-the-immunological-response-to-covid-19-infections/ 2022-09-09T11:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/1-eqjzNB.jpeg https://medicaex.com/prnewswire/waterdrop-inc-announces-second-quarter-2022-unaudited-financial-results/ 2022-09-09T09:00:14+00:00 https://medicaex.com/prnewswire/lifetech-scientific-corporation-1302-hk-announces-2022-interim-results/ 2022-09-09T01:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-chZeCV.jpeg https://medicaex.com/prnewswire/innovents-sintilimab-plus-chemotherapy-demonstrated-pfs-benefit-in-patients-with-egfr-mutated-non-squamous-non-small-cell-lung-cancer-in-the-second-interim-analysis-results-of-the-orient-31-study/ 2022-09-09T01:00:29+00:00 https://medicaex.com/prnewswire/dizal-announces-positive-phase-i-clinical-trial-results-for-dzd1516-in-treating-her2-breast-cancer-at-2022-esmo/ 2022-09-08T21:00:44+00:00 https://medicaex.com/prnewswire/optina-diagnostics-earns-frost-sullivans-2022-north-american-technology-innovation-leadership-award-for-leveraging-innovative-eye-imagery-and-artificial-intelligence-for-chronic-diseases-detec/ 2022-09-08T13:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/09/Optina_Diagnostics_Award_Logo-ZkcGiL.jpeg https://medicaex.com/prnewswire/pulnovo-medical-limiteds-padn-technology-included-in-2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-ph/ 2022-09-08T13:00:25+00:00 https://medicaex.com/prnewswire/biosion-inc-appoints-dr-rakesh-dixit-adc-thought-leader-to-advisory-board/ 2022-09-08T13:00:24+00:00 https://medicaex.com/prnewswire/jacobio-completes-first-dose-of-iia-clinical-trial-of-jab-21822-on-kras-g12c-and-stk11-co-mutation-in-china/ 2022-09-08T12:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-e3QP1N.jpeg https://medicaex.com/prnewswire/recruitment-opens-for-phase-ii-trial-in-prostate-cancer-with-cu-64-sar-bombesin-in-the-us/ 2022-09-08T12:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/09/Clarity_Large_Logo_high_res_ID_42691c6bc5c0_Logo-e1IJgm.jpeg https://medicaex.com/prnewswire/ossur-acquires-naked-prosthetics/ 2022-09-08T12:00:39+00:00 https://medicaex.com/prnewswire/lianhua-products-designated-as-epidemic-prevention-supplies-2022-ciftis/ 2022-09-08T12:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Booth_Yiling_Pharmaceutical-0IyNUs.jpeg https://medicaex.com/prnewswire/fii-institute-looks-to-identify-the-highest-priority-for-each-segment-of-society-at-new-york-summit/ 2022-09-08T12:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/09/FII_Institute_Logo-1FXaeD.jpeg https://medicaex.com/prnewswire/the-first-axa-medical-centre-officially-unveils/ 2022-09-08T10:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_5000630_29176456-7z4YoH.jpeg https://medicaex.com/prnewswire/tikomeds-drug-candidate-ilb-inhibited-infection-of-human-cells-by-dengue-zika-and-yellow-fever-viruses-in-vitro-providing-further-support-for-its-broad-spectrum-mechanism-of-action/ 2022-09-08T08:00:28+00:00 https://medicaex.com/prnewswire/cytiva-launches-biochallenge-in-southeast-asia-to-support-biotech-startup-development/ 2022-09-08T08:00:26+00:00 https://medicaex.com/prnewswire/sirnaomics-to-present-at-3rd-annual-jefferies-asia-forum/ 2022-09-08T07:00:32+00:00 https://medicaex.com/prnewswire/bgi-led-research-builds-the-worlds-first-spatiotemporal-map-of-brain-regeneration/ 2022-09-08T00:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/09/A_single_cell_resolution_spatiotemporal_atlas_axolotl_brain_telencephalon_regeneration-uHLMqK.jpeg https://medicaex.com/prnewswire/fondazione-prada-presents-human-brains-preserving-the-brain-forum-on-neurodegenerative-diseases/ 2022-09-08T00:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/Fondazione_Prada_Human_Brains-jxWgOj.jpeg https://medicaex.com/prnewswire/bridge-biotherapeutics-presented-non-clinical-study-results-for-2-ipf-candidates-at-the-ipf-summit-2022/ 2022-09-07T13:01:00+00:00 https://medicaex.com/prnewswire/tycoon-group-signs-cooperation-agreement-with-jd-logistics-obtains-operating-rights-of-logistics-supply-chain-industry-bases-in-france/ 2022-09-07T13:00:16+00:00 https://medicaex.com/prnewswire/wetrade-group-intends-to-enter-exclusive-strategic-partnership-with-jiqing-bio-regarding-exclusive-monkeypox-test-kits-sales-channel-globally/ 2022-09-07T12:00:29+00:00 https://medicaex.com/prnewswire/licensing-and-agency-agreement-signed-between-beijing-minhai-biokangtai-and-phil-pharmawealth-inc/ 2022-09-07T11:00:53+00:00 https://medicaex.com/prnewswire/prolonging-healthspan-by-delaying-ageing-nuhs-opens-singapores-first-centre-for-healthy-longevity-to-increase-healthy-lifespan-of-singapore-population-by-five-more-disease-free-years/ 2022-09-07T06:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/NUHS_Centre_for_Healthy_Longevity-0PdKQ3.jpeg https://medicaex.com/prnewswire/next-generation-egfr-tki-h002-from-redcloud-bio-completes-first-dose-in-non-small-cell-lung-cancer/ 2022-09-06T22:00:42+00:00 https://medicaex.com/prnewswire/vernalis-research-a-fully-owned-subsidiary-of-hitgen-inc-and-unison-medicines-inc-announce-a-research-collaboration-in-the-field-of-anti-infectives/ 2022-09-06T22:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/09/HitGen_Logo-Cp4wEO.jpeg https://medicaex.com/prnewswire/thailand-heightens-its-healthcare-hub-ambition-with-integrative-medicine/ 2022-09-06T13:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/DITP_Medical_release_F1-adEw3Z.jpeg https://medicaex.com/prnewswire/alterity-therapeutics-launches-ath434-phase-2-clinical-trial-for-the-treatment-of-patients-with-multiple-system-atrophy-in-europe/ 2022-09-06T09:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/09/Alterity_Logo-qEFT6J.jpeg https://medicaex.com/prnewswire/simcere-pharmaceutical-announces-financial-results-for-2022-h1-27-year-over-year-revenue-growth-with-innovative-drugs-accounting-for-65-4-of-total-revenue/ 2022-09-06T09:00:30+00:00 https://medicaex.com/prnewswire/amcor-reveals-lift-off-seed-capital-winners-with-investments-that-seek-to-drive-the-revolution-in-packaging/ 2022-09-06T09:00:27+00:00 https://medicaex.com/prnewswire/tamas-oravecz-ph-d-named-svp-cso-of-the-u-s-of-simcere-pharmaceutical-group/ 2022-09-06T08:00:29+00:00 https://medicaex.com/prnewswire/alpha-biopharma-announces-completion-of-its-everest-phase-ii-iii-clinical-study-of-zorifertinib-in-non-small-cell-lung-cancer-patients-with-central-nervous-system-metastases/ 2022-09-06T07:00:42+00:00 https://medicaex.com/prnewswire/prospection-partners-with-leading-japanese-healthcare-data-provider-medical-data-vision-to-improve-treatment-access-for-patients/ 2022-09-06T00:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/09/Prospection_Logo-poUAut.jpeg https://medicaex.com/prnewswire/mangosteen-peel-as-medicine-cus-faculty-of-veterinary-science-is-successful-in-replicating-mangosteen-peel-extract-treatment-for-intestinal-inflammation-in-humans-and-animals/ 2022-09-05T15:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_5019179_38748568-RMLREJ.jpeg https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-the-higher-dose-cohort-of-a-phase-2-clinical-trial-of-mazdutide-in-chinese-adults-with-obesity/ 2022-09-05T15:00:28+00:00 https://medicaex.com/prnewswire/first-us-patient-enrolled-in-selution-slr-ide-peripheral-study/ 2022-09-05T14:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/MedAlliance-30OC96.jpeg https://medicaex.com/prnewswire/targeted-alpha-therapy-candidate-bladder-cancer-study-completes-enrolment/ 2022-09-05T13:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/Telix_Logo-8mFTDD.jpeg https://medicaex.com/prnewswire/prosomnus-sleep-technologies-announces-signing-of-definitive-agreements-for-30-million-of-convertible-notes/ 2022-09-05T13:00:39+00:00 https://medicaex.com/prnewswire/leaders-in-nutritional-medicine-on-cusp-of-breakthrough-guidelines-to-tackle-long-covid-symptoms/ 2022-09-05T13:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/09/MicrosoftTeams_image__4-TbNC9S.jpeg https://medicaex.com/prnewswire/cellorigin-biotech-announced-strategic-global-collaboration-with-qilu-pharmaceutical-to-develop-off-the-shelf-car-imac-cell-therapy/ 2022-09-05T13:00:25+00:00 https://medicaex.com/prnewswire/neukio-biotherapeutics-completed-series-a-1-financing-to-accelerate-discovery-and-development-of-next-generation-cell-therapy-products/ 2022-09-05T10:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/1-IlP3Jn.jpeg https://medicaex.com/prnewswire/jacobio-completes-first-patient-dosage-of-cd73-mab-jab-bx102-in-china/ 2022-09-05T08:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-8xIGCP.jpeg https://medicaex.com/prnewswire/indonesian-health-minister-is-himss22-apac-guest-of-honor/ 2022-09-05T06:00:14+00:00 https://medicaex.com/prnewswire/lunit-ai-solution-for-breast-cancer-detection-wins-commercial-approval-in-taiwan/ 2022-09-05T05:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/09/Lunit_INSIGHT_MMG_Lunit_s_AI_solution_mammography-1dV7G2.jpeg https://medicaex.com/prnewswire/docquity-raises-us44-million-in-series-c-round-led-by-itochu-corporation/ 2022-09-05T03:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/09/Docquity_Logo-EFvGvO.jpeg https://medicaex.com/prnewswire/zhongchao-inc-announces-its-new-strategy-extension-focusing-on-the-oncology-and-other-major-disease-management/ 2022-09-05T02:00:28+00:00 https://medicaex.com/prnewswire/cambrex-completes-first-phase-of-30-million-capacity-expansion-project-in-high-point-north-carolina/ 2022-09-05T00:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Cambrex_1-AylIy5.jpeg https://medicaex.com/prnewswire/aston-sci-receives-ind-approval-from-u-s-fda-for-phase-2-clinical-trial-of-the-therapeutic-cancer-vaccine-ast-301-in-patients-with-her2-1-2-breast-cancer/ 2022-09-05T00:00:25+00:00 https://medicaex.com/prnewswire/juniper-biologics-pte-ltd-signs-exclusive-license-agreement-with-helsinn-healthcare-sa-for-ledaga-chlormethine-in-australia-asia-and-the-middle-east/ 2022-09-04T23:00:28+00:00 https://medicaex.com/prnewswire/ubtech-announces-global-debut-of-intelligent-healthcare-robots-and-solutions/ 2022-09-02T20:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_1-qb3UgU.jpeg https://medicaex.com/prnewswire/new-building-stands-as-symbol-of-dignity-and-hope-for-persons-affected-by-leprosy-in-ethiopia/ 2022-09-02T15:00:11+00:00 https://medicaex.com/wp-content/uploads/2022/09/Ethiopia_Opening_Ceremony-lYmfGD.jpeg https://medicaex.com/prnewswire/antengene-announces-xpovio-included-for-reimbursement-by-the-pbs-in-australia-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma/ 2022-09-02T13:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/09/ANTENGENE_EN_Logo-SAM5Z6.jpeg https://medicaex.com/prnewswire/waterdrop-inc-to-report-second-quarter-2022-financial-results-on-september-9-2022/ 2022-09-02T13:00:11+00:00 https://medicaex.com/prnewswire/brii-biosciences-appoints-taiyin-yang-to-board-of-directors-strengthening-product-quality-oversight-to-support-company-momentum/ 2022-09-02T11:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-TfFP7y.jpeg https://medicaex.com/prnewswire/clarity-advances-to-cohort-3-of-the-cl04-trial-of-sartate-in-paediatric-neuroblastoma/ 2022-09-02T09:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/09/Clarity_Large_Logo_high_res_ID_42691c6bc5c0_Logo-yZ2qTE.jpeg https://medicaex.com/prnewswire/ai-startup-aesop-raises-3m-to-tackle-medical-and-billing-errors/ 2022-09-02T09:00:29+00:00 https://medicaex.com/prnewswire/nuance-pharma-announces-clearance-of-ind-application-for-ensifentrine-pivotal-clinical-trials-for-copd-in-china/ 2022-09-02T01:00:47+00:00 https://medicaex.com/prnewswire/mayo-clinic-hibiscus-bioventures-and-innoforce-announce-mayflower-cell-and-gene-therapy-accelerator/ 2022-09-02T01:00:30+00:00 https://medicaex.com/prnewswire/quint-founders-donate-usd-16-million-to-establish-the-quint-bone-marrow-transplant-centre-in-dubai/ 2022-09-02T00:00:13+00:00 https://medicaex.com/wp-content/uploads/2022/09/QUINT_Transplant_Centre-oygn7b.jpeg https://medicaex.com/prnewswire/pxierra-is-launching-worlds-first-non-contact-heart-rate-breathe-rate-measurement-ai-baby-monitor/ 2022-09-01T14:00:17+00:00 https://medicaex.com/prnewswire/bgi-group-included-in-first-fortune-china-esg-list/ 2022-09-01T13:00:42+00:00 https://medicaex.com/prnewswire/wuxi-biologics-announces-gmp-release-of-its-first-north-american-biomanufacturing-facility-in-cranbury-new-jersey/ 2022-09-01T13:00:33+00:00 https://medicaex.com/prnewswire/global-wellness-leader-iherb-celebrates-its-26th-anniversary-of-making-health-wellness-products-easy-and-affordable/ 2022-09-01T13:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/iHerb_Logo-0XqNgZ.jpeg https://medicaex.com/prnewswire/quris-earns-frost-sullivan-2022-europe-technology-innovation-leadership-award-for-ai-powered-drug-safety-prediction/ 2022-09-01T11:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/09/Quris_Technologies_Award_Logo-lxxPPx.jpeg https://medicaex.com/prnewswire/tikomeds-ilb-mobilizes-and-modulates-key-growth-factors-that-trigger-a-cascade-of-neuroprotective-mechanisms-able-to-target-all-neuroinflammation-driven-diseases-including-als/ 2022-09-01T09:00:31+00:00 https://medicaex.com/prnewswire/top-healthcare-executive-sets-up-fundraising-platform-matching-healthcare-startups-to-medical-investors/ 2022-09-01T02:00:18+00:00 https://medicaex.com/wp-content/uploads/2022/09/Chris_Lee_VentureBlick-zWVdzT.jpeg https://medicaex.com/prnewswire/breast-cancer-ai-company-fathomx-raises-sgd-2-24-million-in-pre-series-a-funding/ 2022-09-01T01:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/Product_Photo_Finalised_CLEAN-dKSCen.jpeg https://medicaex.com/prnewswire/gc-biopharma-and-speragen-sponsored-an-externally-led-patient-focused-drug-development-with-fda-attendance/ 2022-08-31T23:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/GC_Biopharma_Logo-7MxgaC.jpeg https://medicaex.com/prnewswire/cancer-treatment-with-the-worlds-smallest-rotating-gantry-began-at-yamagata-university-in-2022-taking-on-the-challenge-of-global-standardization-of-heavy-ion-therapy-equipment/ 2022-08-31T17:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/09/HeavyIon_Banner-eu3Rqs.jpeg https://medicaex.com/prnewswire/antengene-announces-interim-2022-financial-results-and-provides-corporate-update/ 2022-08-31T16:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/ANTENGENE_EN_Logo-6xI398.jpeg https://medicaex.com/prnewswire/aesop-technology-wins-coveted-place-in-mayo-clinic-platform_accelerate-program-to-build-better-ai-model-for-healthcare/ 2022-08-31T14:00:44+00:00 https://medicaex.com/prnewswire/biomedical-industry-bears-fruit-again-in-national-nanning-economic-technological-development-area/ 2022-08-31T14:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Production_workshop-eiIPTP.jpeg https://medicaex.com/prnewswire/fosun-pharma-announces-2022-interim-results/ 2022-08-31T12:00:30+00:00 https://medicaex.com/prnewswire/sirnaomics-doses-the-first-patient-in-phase-i-ii-clinical-study-of-rnai-therapeutic-stp705-for-treatment-of-facial-squamous-cell-skin-cancer-in-situ/ 2022-08-31T09:00:53+00:00 https://medicaex.com/prnewswire/i-mab-provides-business-and-corporate-updates-and-reports-financial-results-for-the-six-months-ended-june-30-2022/ 2022-08-31T07:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/08/1-30jQdj.jpeg https://medicaex.com/prnewswire/vitallife-achieves-ghas-certification-for-excellence-in-medical-travel-patient-experience/ 2022-08-31T04:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/08/Global_Healthcare_Accreditation-zz2hR4.jpeg https://medicaex.com/prnewswire/catalytic-investment-to-improve-community-health-care-for-millions-across-africa/ 2022-08-31T04:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/08/The_Global_Fund_Logo-1d7xbW.jpeg https://medicaex.com/prnewswire/pet-telemedicine-platform-pawlyclinic-expands-to-indonesia-to-make-veterinary-care-more-easily-accessible-across-southeast-asia/ 2022-08-31T04:00:21+00:00 https://medicaex.com/wp-content/uploads/2022/08/Pawlyclinic_Horizontal_Full_Colour_Medium_Logo-vWrZFa.jpeg https://medicaex.com/prnewswire/dxgen-corp-and-precision-diabetes-inc-announce-strategic-partnership-to-launch-new-diabetes-point-of-care-testing-analyzer-into-the-u-s-market/ 2022-08-31T03:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/08/Precision_Diabetes_Logo-O9YKQm.jpeg https://medicaex.com/prnewswire/medlab-asia-asia-health-2022-to-promote-thailand-as-a-medical-hub-of-asean-by-collaborating-with-department-of-health-service-support-and-medical-industry/ 2022-08-31T03:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/08/43FDA5806E59321A9C9A199AC46189089533A34E-VOEaK9.jpeg https://medicaex.com/prnewswire/fosun-international-announces-2022-interim-results-total-revenue-amounted-to-rmb82-89-billion-representing-a-year-on-year-increase-of-17-7/ 2022-08-31T03:00:16+00:00 https://medicaex.com/prnewswire/nreal-air-ar-glasses-receive-tuv-rheinland-eye-comfort-ar-certification/ 2022-08-31T03:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/08/image-Xo7FeP.jpeg https://medicaex.com/prnewswire/new-report-highlights-the-technology-key-to-fighting-future-pandemics/ 2022-08-31T00:00:31+00:00 https://medicaex.com/prnewswire/kintor-announces-2022-interim-results-and-recent-business-update/ 2022-08-30T16:00:32+00:00 https://medicaex.com/prnewswire/tycoon-group-announces-2022-interim-results/ 2022-08-30T16:00:17+00:00 https://medicaex.com/prnewswire/waterdrop-receives-the-nbd-2022-green-practice-pioneering-projects/ 2022-08-30T15:00:16+00:00 https://medicaex.com/prnewswire/airs-medical-raises-20m-in-series-b-funding/ 2022-08-30T14:00:50+00:00 https://medicaex.com/wp-content/uploads/2022/08/image-9aVrhU.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-to-participate-in-four-upcoming-investor-conferences/ 2022-08-30T14:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-muTavp.jpeg https://medicaex.com/prnewswire/zylox-tonbridge-maintains-strong-revenue-and-gross-profit-growth-including-gross-margin-improvement-driven-by-its-platform-based-strategy-in-1h22/ 2022-08-30T13:00:51+00:00 https://medicaex.com/prnewswire/joysbio-has-developed-new-monkeypox-rapid-tests/ 2022-08-30T12:00:46+00:00 https://medicaex.com/prnewswire/sirnaomics-achieves-100-complete-response-in-phase-ii-clinical-trial-of-stp705-for-treatment-of-cutaneous-basal-cell-carcinoma/ 2022-08-30T12:00:35+00:00 https://medicaex.com/prnewswire/recbio-announces-interim-results-for-the-fiscal-year-2022-and-company-progress/ 2022-08-30T10:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/08/Recbio_Logo-gQ6eRT.jpeg https://medicaex.com/prnewswire/porton-advanced-and-royaltech-announce-strategic-collaboration-to-accelerate-the-development-of-bacterial-drugs-and-mrna-drugs/ 2022-08-30T10:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/08/Porton_Advance_photo-rYtxBv.jpeg https://medicaex.com/prnewswire/sanyou-biopharmaceuticals-and-kangabio-established-strategic-collaboration-to-accelerate-antibody-drug-development-and-innovation/ 2022-08-30T07:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-Z4dKpC.jpeg https://medicaex.com/prnewswire/baxter-hosts-2022-digital-surgery-summit-reimagining-connected-surgery/ 2022-08-30T03:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/08/Baxter_PNG_Logo_Logo-6UUqNM.jpeg https://medicaex.com/prnewswire/infinitus-co-organizes-traditional-chinese-medicine-cultural-communication-%e2%96%aa-we-are-in-action-event/ 2022-08-30T02:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_1-jL1p3u.jpeg https://medicaex.com/prnewswire/viva-biotech-announced-2022-interim-results/ 2022-08-29T17:00:13+00:00 https://medicaex.com/prnewswire/ascentage-pharma-announces-2022-interim-results/ 2022-08-29T16:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Ascentage_Pharma_Logo-qeuhWq.jpeg https://medicaex.com/prnewswire/ocumension-releases-its-2022-interim-report-with-its-core-product-youshiying-being-approved-for-marketing-continuously-accelerating-product-commercialization/ 2022-08-29T13:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_964661_47732353_Logo-emW9Wr.jpeg https://medicaex.com/prnewswire/sirnaomics-advances-galaheadtm-based-rnai-therapeutics-for-treatment-of-complement-related-diseases/ 2022-08-29T11:00:30+00:00 https://medicaex.com/prnewswire/first-approval-of-cadonilimab-pd-1-ctla-4-bispecific-published-in-drugs-a-peer-reviewed-medical-journal/ 2022-08-29T08:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/logo_Logo-Wx6vTS.jpeg https://medicaex.com/prnewswire/increased-precision-and-safety-in-spinal-tap-with-pass-an-ultrasound-guided-lumbar-puncture-procedure/ 2022-08-29T07:00:53+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_5019179_33107288-PPA0Lm.jpeg https://medicaex.com/prnewswire/kira-pharmaceuticals-to-present-new-preclinical-data-on-lead-asset-kp104-at-the-2022-european-meeting-on-complement-in-human-disease-conference/ 2022-08-29T07:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/08/Kira_Pharmaceuticals_Logo-xhkcsx.jpeg https://medicaex.com/prnewswire/aquilavie-launches-safe-and-painless-aq-lollipop-dual-use-covid-19-rapid-test-kit-for-kids-in-discounted-back-to-school-bundle/ 2022-08-29T07:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_5015312_26853468-fAw41W.jpeg https://medicaex.com/prnewswire/pfizer-ranked-leading-company-in-asia-for-covid-19-response-and-patient-centric-approach-by-asian-patient-groups/ 2022-08-29T05:00:38+00:00 https://medicaex.com/prnewswire/thousands-around-the-world-give-blood-for-globalbloodheroes-day-27-august-2022/ 2022-08-29T04:00:20+00:00 https://medicaex.com/wp-content/uploads/2022/08/Who_is_Hussain-Zbl0eU.jpeg https://medicaex.com/prnewswire/first-vietnams-natural-mineral-water-brand-provides-perfect-alkalinity-ph-9-0-from-the-premium-unique-mineral-source-of-danh-thanh/ 2022-08-29T03:00:19+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_5014040_38485672-DFp2Su.jpeg https://medicaex.com/prnewswire/everest-medicines-announces-the-departure-of-ceo-kerry-blanchard/ 2022-08-28T00:00:33+00:00 https://medicaex.com/prnewswire/wetrade-group-inc-announces-strategic-cooperation-with-mobilab-medical-innovatives-inc-globally-launching-an-unparalleled-and-one-of-a-kind-monkeypox-virus-testing-kits-with-combined-insurance-cove/ 2022-08-26T20:00:45+00:00 https://medicaex.com/prnewswire/doctors-at-manipal-hospitals-dwarka-give-new-lease-of-life-to-a-30-day-old-newborn-suffering-from-brain-tumor/ 2022-08-26T20:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/08/Manipal_Hospitals_Logo-TLSXMF.jpeg https://medicaex.com/prnewswire/innovent-announced-2022-interim-results-and-business-updates/ 2022-08-26T17:00:36+00:00 https://medicaex.com/prnewswire/waterdrop-releases-user-family-insurance-report/ 2022-08-26T15:00:14+00:00 https://medicaex.com/prnewswire/tigermed-reports-2022-interim-result-with-strong-financial-growth/ 2022-08-26T14:00:38+00:00 https://medicaex.com/prnewswire/111-inc-announces-second-quarter-2022-unaudited-financial-results/ 2022-08-26T11:00:36+00:00 https://medicaex.com/prnewswire/vista-eye-specialists-joins-qualitas-health-family-to-further-strengthen-qualitas-healthcare-foothold-in-asia-pacific/ 2022-08-26T01:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/08/fa_qualitas_x_vista_1_02-QhWFss.jpeg https://medicaex.com/prnewswire/asieris-pharmaceuticals-688176-sh-issued-2022-semi-annual-report-accelerated-global-clinical-development-and-progressive-implementation-of-its-integrated-diagnosis-treatment-commercialization-strat/ 2022-08-26T00:00:37+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-interim-results-for-first-half-of-2022/ 2022-08-25T23:00:34+00:00 https://medicaex.com/prnewswire/vision-loss-rehabilitation-canada-brings-ai-driven-diabetic-eye-screening-to-rural-and-indigenous-communities/ 2022-08-25T15:00:50+00:00 https://medicaex.com/wp-content/uploads/2022/08/EYENUK_Logo-uiSnyZ.jpeg https://medicaex.com/prnewswire/carsgen-2022-interim-results-innovative-car-t-cell-technologies-and-robust-pipeline/ 2022-08-25T15:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/08/CARsgen_s_pipeline-LR1J3Y.jpeg https://medicaex.com/prnewswire/cg-pharmaceuticals-announces-first-patient-dosed-in-phase-1b-2-study-evaluating-ivaltinostat-for-the-treatment-of-pancreatic-adenocarcinoma/ 2022-08-25T11:00:58+00:00 https://medicaex.com/prnewswire/cstone-pharmaceuticals-reports-2022-interim-results-and-business-updates/ 2022-08-25T11:00:34+00:00 https://medicaex.com/prnewswire/innovent-announces-first-patient-dosing-in-australia-in-phase-1-study-of-ibi363-pd-1-il-2-bispecific-antibody-fusion-protein-in-patients-with-advanced-malignancies/ 2022-08-25T10:00:31+00:00 https://medicaex.com/prnewswire/brii-biosciences-provides-corporate-update-and-reports-2022-interim-results/ 2022-08-25T06:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/08/EN_Image1_Profit_or_loss_and_other_income-veDHBG.jpeg https://medicaex.com/prnewswire/case-report-of-long-term-complete-response-in-hepatocellular-carcinoma-to-carsgens-gpc3-car-t-cells-ct011-published-in-frontiers-in-immunology/ 2022-08-25T02:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/08/Changes_No_3_target_lesion-5JtVw3.jpeg https://medicaex.com/prnewswire/dfi-unveils-atx-motherboard-icx610-c621a-facilitating-the-integration-of-ai-computing/ 2022-08-25T02:00:09+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_846719_10406485-Y2UxOI.jpeg https://medicaex.com/prnewswire/jacobio-pharma-announces-2022-interim-results/ 2022-08-24T17:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-V3BLZZ.jpeg https://medicaex.com/prnewswire/icp-das-bmp-will-attend-medical-manufacturing-asia-2022-in-singapore/ 2022-08-24T15:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/08/image-JVPrwC.jpeg https://medicaex.com/prnewswire/mgi-wins-ibo-design-gold-award-for-dnbelab-c4-pocket-single-cell-lab/ 2022-08-24T15:00:15+00:00 https://medicaex.com/prnewswire/ceo-of-waterdrop-peng-shen-was-appointed-as-vice-chairman-of-the-overseas-students-and-chinese-committee-of-the-beijing-youth-federation/ 2022-08-24T15:00:14+00:00 https://medicaex.com/prnewswire/i-mab-announces-share-purchase-plans-by-the-company-and-the-senior-management/ 2022-08-24T13:00:57+00:00 https://medicaex.com/wp-content/uploads/2022/08/logo_Logo-ai0CaU.jpeg https://medicaex.com/prnewswire/mgi-supports-the-ministry-of-health-of-indonesia-in-the-countrys-breakthrough-national-genome-project/ 2022-08-24T10:00:25+00:00 https://medicaex.com/prnewswire/biorchestra-appointed-dr-gabriel-helmlinger-ph-d-dabt-as-head-of-translational-and-clinical-pharmacology-toxicology/ 2022-08-24T09:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/08/Dr_Gabriel_Helmlinger_Vice_President_BIORCHESTRA_US-9cRq0w.jpeg https://medicaex.com/prnewswire/genfleet-receives-fda-approval-for-phase-ii-study-of-ripk1-inhibitor-gfh312/ 2022-08-24T02:00:42+00:00 https://medicaex.com/prnewswire/rokit-healthcare-to-enable-innovation-in-treatment-of-diabetes-foot-and-osteoarthritis-combining-ai-and-3d-bioprinting-on-google-cloud/ 2022-08-24T02:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_1-509Zuj.jpeg https://medicaex.com/prnewswire/brii-biosciences-appoints-eleanor-de-groot-as-chief-technology-officer-and-aleksandar-skuban-as-central-nervous-system-diseases-therapy-area-head/ 2022-08-24T01:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-cXBq3T.jpeg https://medicaex.com/prnewswire/eccogene-announces-us-ind-approval-for-thr%ce%b2-agonist-ecc4703/ 2022-08-24T01:00:07+00:00 https://medicaex.com/prnewswire/j-ints-bio-oral-presentation-of-preclinical-results-of-its-novel-oral-4th-generation-egfr-tki-jin-a02-at-the-2022-world-conference-on-lung-cancer-in-vienna-austria-iaslc-2022-wclc/ 2022-08-23T22:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/08/J_INTS_BIO__Oral_presentation_of_Preclinical_results_of_its_Novel_Oral_4th_Generation_EGFR_TKI__JIN-opE1YJ.jpeg https://medicaex.com/prnewswire/avelos-therapeutics-announces-8-millon-series-a-funding-round/ 2022-08-23T22:00:22+00:00 https://medicaex.com/prnewswire/prominent-ophthalmologist-will-guide-turn-bios-search-for-therapies-to-cure-eye-diseases/ 2022-08-23T16:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/08/Albert_Wu_Turn_Biotechnologies-i6Yyf7.jpeg https://medicaex.com/prnewswire/img-renews-sponsorship-with-school-the-world-employees-to-go-on-corporate-service-trip/ 2022-08-23T14:00:12+00:00 https://medicaex.com/wp-content/uploads/2022/08/International_Medical_Group_Logo-Y2CKMx.jpeg https://medicaex.com/prnewswire/antengene-announces-first-patient-dosed-of-small-molecule-atr-atg-018-for-the-treatment-of-patients-with-advanced-solid-tumors-and-hematologic-malignancies-in-australia/ 2022-08-23T13:00:55+00:00 https://medicaex.com/wp-content/uploads/2022/08/ANTENGENE_EN_Logo-21ocYO.jpeg https://medicaex.com/prnewswire/lts-takes-next-step-in-its-growth-journey-with-the-acquisition-of-tapemark-inc/ 2022-08-23T13:00:35+00:00 https://medicaex.com/prnewswire/announcement-of-2022-future-science-prize-winners-wenhui-li-xueming-yang-ngaiming-mok/ 2022-08-23T13:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/08/1-hGV0ia.jpeg https://medicaex.com/prnewswire/ubie-japanese-health-tech-startup-raises-26-2-million-in-series-c-59-8-million-in-total/ 2022-08-23T12:00:24+00:00 https://medicaex.com/prnewswire/mgi-honored-with-2022-stevie-award-for-most-valuable-covid-19-corporate-response/ 2022-08-23T11:00:09+00:00 https://medicaex.com/prnewswire/genscript-probio-congratulates-selecxine-on-fda-clearance-of-ind-application-for-innovative-antibody-drug-program/ 2022-08-23T07:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/08/GENSCRIPT__Logo-Z9zHT2.jpeg https://medicaex.com/prnewswire/biosion-inc-appoints-steven-knapp-pharm-d-as-chief-regulatory-quality-officer/ 2022-08-23T06:00:35+00:00 https://medicaex.com/prnewswire/sirnaomics-becoming-a-constituent-of-hang-seng-family-of-indexes/ 2022-08-22T23:02:30+00:00 https://medicaex.com/prnewswire/australians-takes-part-in-world-blood-donation-record-attempt-to-save-lives/ 2022-08-22T23:02:26+00:00 https://medicaex.com/wp-content/uploads/2022/08/WIH_Campaign-5X13Yg.jpeg https://medicaex.com/prnewswire/i-mab-to-report-business-and-corporate-updates-and-financial-results-for-the-six-months-ended-june-30-2022-on-august-30-2022/ 2022-08-22T16:01:08+00:00 https://medicaex.com/wp-content/uploads/2022/08/logo_Logo-cH2mcM.jpeg https://medicaex.com/prnewswire/waterdrop-joins-the-united-nations-global-compact/ 2022-08-22T15:00:22+00:00 https://medicaex.com/prnewswire/full-life-technologies-deepens-radioisotope-technology-expertise-with-key-leadership-appointments-and-the-establishment-of-a-radioisotope-technology-advisory-board/ 2022-08-22T12:00:46+00:00 https://medicaex.com/prnewswire/united-imaging-healthcare-announces-listing-of-initial-public-offering/ 2022-08-22T05:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/08/United_Imaging_Healthcare_STAR_Market-0HcZGE.jpeg https://medicaex.com/prnewswire/sirnaomics-doses-the-first-patient-in-phase-i-ii-clinical-study-of-rnai-therapeutic-stp705-for-treatment-of-facial-squamous-cell-skin-cancer-in-situ-2/ 2022-08-22T02:00:37+00:00 https://medicaex.com/prnewswire/completion-of-subject-enrollment-and-vaccination-for-the-comparative-study-between-recov-and-mrna-vaccines/ 2022-08-22T02:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/08/Recbio_Logo-zjUp3t.jpeg https://medicaex.com/prnewswire/j-ints-bio-successfully-held-its-1st-international-advisory-board-meeting-for-its-novel-oral-4th-generation-egfr-tki-jin-a02-in-vienna-austria-during-wclc/ 2022-08-22T02:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/08/J_INTS_BIO_successfully_held_its_1st_International_Advisory_Board_Meeting_for_its_Novel_Oral_4th_Gen-tpaKFy.jpeg https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-oral-rdrp-inhibitor-asc10-for-covid-19-by-china-nmpa/ 2022-08-22T02:00:33+00:00 https://medicaex.com/prnewswire/yilings-lianhua-health-products-well-received-cicpe/ 2022-08-22T02:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/08/Yiling_Pharma_Booth-XQpoqK.jpeg https://medicaex.com/prnewswire/waterdrop-unveiled-its-first-digital-employee-waterdrop-assistant/ 2022-08-22T02:00:15+00:00 https://medicaex.com/prnewswire/ulab-systems-ranked-in-top-20-of-the-inc-5000-annual-list-of-the-fastest-growing-companies-in-america/ 2022-08-18T16:05:06+00:00 https://medicaex.com/wp-content/uploads/2022/08/ulab_Logo-IHdcem.jpeg https://medicaex.com/prnewswire/jin-a02-a-novel-4th-generation-egfr-tki-selected-for-the-european-thoracic-oncology-platform-a-first-for-korean-pharma/ 2022-08-18T15:03:05+00:00 https://medicaex.com/wp-content/uploads/2022/08/JINTSBIO-Z2AvxF.jpeg https://medicaex.com/prnewswire/bridge-biotherapeutics-receives-fda-authorization-to-proceed-with-phase-2-study-of-bbt-877/ 2022-08-18T15:03:04+00:00 https://medicaex.com/prnewswire/prenetics-launches-circle-snapshot-simple-at-home-blood-tests-using-the-worlds-first-push-button-and-painless-blood-collection-device/ 2022-08-18T15:02:52+00:00 https://medicaex.com/prnewswire/standigm-names-carl-foster-chief-business-officer-to-expand-strategic-partnerships-for-ai-drug-discovery/ 2022-08-18T15:02:18+00:00 https://medicaex.com/wp-content/uploads/2022/08/Standigm_B_W_Logo-0qBTT4.jpeg https://medicaex.com/prnewswire/ybrain-receives-translational-research-award-2022-neuroergonomics-conference-nyc-neuromodulation-conference/ 2022-08-18T15:02:18+00:00 https://medicaex.com/wp-content/uploads/2022/08/Ybrain_Photo-DpfF1u.jpeg https://medicaex.com/prnewswire/ping-an-health-posts-revenue-of-rmb2828-million-in-the-first-half-of-2022/ 2022-08-18T15:02:15+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_5011882_46933152-lUjkkf.jpeg https://medicaex.com/prnewswire/innovent-announces-first-subject-dosed-in-phase-1-study-of-ibi311-anti-igf-1r-monoclonal-antibody/ 2022-08-18T14:00:49+00:00 https://medicaex.com/prnewswire/henlius-2022-h1-results-sharpen-all-round-edges-advance-in-evolution-to-biopharma/ 2022-08-18T14:00:44+00:00 https://medicaex.com/prnewswire/menarini-groups-elacestrant-granted-priority-review-by-the-u-s-fda-for-patients-with-er-her2-advanced-or-metastatic-breast-cancer/ 2022-08-18T13:01:02+00:00 https://medicaex.com/wp-content/uploads/2022/08/MENARINI_GROUP-Ix1hSg.jpeg https://medicaex.com/prnewswire/akso-health-group-receives-notice-of-filing-delinquency-from-nasdaq/ 2022-08-18T13:00:40+00:00 https://medicaex.com/prnewswire/wuxi-biologics-reports-strong-2022-interim-results/ 2022-08-18T13:00:39+00:00 https://medicaex.com/prnewswire/ecolab-names-gregory-lukasik-senior-vice-president-and-market-head-for-southeast-asia/ 2022-08-18T13:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/08/Greg_Lukasik-1LFbuh.jpeg https://medicaex.com/prnewswire/wetrade-group-inc-ready-to-kick-off-a-strategic-partnership-with-zhixun-bio-through-wetrades-saas-platform-and-its-the-internet-of-things-iot/ 2022-08-18T13:00:17+00:00 https://medicaex.com/prnewswire/arbele-announces-phase-1-first-in-human-study-of-cdh17xcd3-bispecific-t-cell-engager-for-treatment-of-gastrointestinal-cancers/ 2022-08-18T11:00:59+00:00 https://medicaex.com/prnewswire/global-cord-blood-corporation-files-annual-report-on-form-20-f/ 2022-08-18T11:00:37+00:00 https://medicaex.com/prnewswire/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader/ 2022-08-18T08:00:29+00:00 https://medicaex.com/prnewswire/the-worlds-leading-brand-of-fashionable-colored-masks-officially-launches-on-amazon-on-august-8th-from-csd-a-professional-disposable-medical-supplies-manufacturer-in-taiwan/ 2022-08-18T07:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/08/COLO_COLOMOOD-IP96F0.jpeg https://medicaex.com/prnewswire/wuxi-sta-breaks-ground-for-new-pharmaceutical-manufacturing-facility-in-middletown-delaware/ 2022-08-18T07:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Photo1-JdvBX5.jpeg https://medicaex.com/prnewswire/picarro-introduces-the-first-automated-solution-for-continuous-ethylene-oxide-monitoring/ 2022-08-17T15:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/08/Ambient_Air_Monitoring_System-JpdsKV.jpeg https://medicaex.com/prnewswire/waterdrop-insurance-marketplace-opens-its-first-agency-outlet-in-wuhan/ 2022-08-17T15:00:12+00:00 https://medicaex.com/prnewswire/standigm-wins-gold-and-bronze-stevie-awards-in-2022-international-business-awards/ 2022-08-17T14:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Standigm_B_W_Logo-puyNv3.jpeg https://medicaex.com/prnewswire/universe-pharmaceuticals-inc-reports-financial-results-for-the-first-six-months-of-fiscal-year-2022/ 2022-08-17T13:00:38+00:00 https://medicaex.com/prnewswire/announcing-the-release-of-the-disruptors-the-first-comprehensive-documentary-film-on-adhd-award-winning-star-studded-documentary-available-in-australia-on-apple-tv-itunes/ 2022-08-17T13:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/08/Disruptors_winposter_page_001-3IZ2Hf.jpeg https://medicaex.com/prnewswire/bridge-biotherapeutics-presents-promising-interim-clinical-study-results-from-phase-1-study-of-bbt-176-at-wclc-2022/ 2022-08-17T12:01:00+00:00 https://medicaex.com/prnewswire/vela-diagnostics-supports-covid-19-surveillance-efforts-in-kenya/ 2022-08-17T12:00:25+00:00 https://medicaex.com/prnewswire/medison-pharma-announces-the-expansion-of-its-partnership-with-albireo-to-a-multi-regional-agreement-to-commercialize-odevixibat-in-canada-and-israel/ 2022-08-17T10:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/08/MEDISON_Logo-SB5mMP.jpeg https://medicaex.com/prnewswire/vieworks-wins-fda-approval-for-its-newest-vivix-s-f-series/ 2022-08-17T06:00:49+00:00 https://medicaex.com/wp-content/uploads/2022/08/18_Group_1-30hCAa.jpeg https://medicaex.com/prnewswire/wuxi-biologics-again-selected-as-constituent-of-ftse4good-index-series/ 2022-08-17T03:00:14+00:00 https://medicaex.com/prnewswire/radiopharm-enters-into-strategic-collaboration-with-lantheus-and-assumes-pd-l1-licensing-agreement-from-nanomab/ 2022-08-17T02:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-6FfSg9.jpeg